Patrick Mayrhofer

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 4

Top Topics

Molecular Docking

Binding Protein

Saccharomyces Cerevisiae

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Biotechnology progress

Applied microbiology and biotechnology

University of Natural Resources and Life Sciences

University of Natural Resources and Life Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Natural Resources and Life Sciences Aug 1o 2016

Austria

PostDoc :: Department of Biotechnology, group Prof. Kunert

Education History

University of Natural Resources and Life Sciences Mar 1o 2013 - Jul 1o 2016

Austria

PHD :: Department of Biotechnology, group Prof. Kunert

Publications

Somanath Kallolimath, Lin Sun, Roman Palt, Karin Stiasny, Patrick Mayrhofer, Clemens Gruber, Benjamin Kogelmann, Qiang Chen, Herta Steinkellner
Highly active engineered IgG3 antibodies against SARS-CoV-2. Proceedings of the National Academy of Sciences of the United States of America 118 (42) (2021)
Lin Sun, Somanath Kallolimath, Roman Palt, Karin Stiasny, Patrick Mayrhofer, Daniel Maresch, Lukas Eidenberger, Herta Steinkellner
Increased in vitro neutralizing activity of SARS-CoV-2 IgA1 dimers compared to monomers and IgG. Proceedings of the National Academy of Sciences of the United States of America 118 (44) (2021)
Linda Schwaigerlehner, Patrick Mayrhofer, Matthias Diem, Willibald Steinfellner, Emma Fenech, Chris Oostenbrink, Renate Kunert
Germinality does not necessarily define mAb expression and thermal stability. Applied microbiology and biotechnology 103 (18) (2019)
Patrick Mayrhofer, David Reinhart, Andreas Castan, Renate Kunert
Rapid development of clone-specific, high-performing perfusion media from established feed supplements. Biotechnology progress 36 (2) (2019)